Varex Imaging (VREX) Stock Forecast & Price Target

Varex Imaging Corp has demonstrated significant growth across its segments, with the industrial segment achieving a record revenue of $76.8 million, a year-over-year increase of 25.3%, primarily due to strong shipments in cargo inspection systems. Additionally, the medical segment has shown resilience, growing 5.3% year-over-year to $152.1 million, supported by improved market conditions in China and increased tender activities related to healthcare expansion. Overall, Varex's strategic initiatives, including the development of manufacturing capabilities in India and advancements in photon counting CT technology, position the company well for continued revenue growth and operational efficiency in FY2026.

Varex Imaging's stock outlook is negatively impacted by the ongoing trade tensions between the U.S. and China, which are anticipated to hinder approximately 15% of the company's total revenues. Additionally, the challenges of navigating the Chinese market, compounded by the Chinese government's anti-corruption measures, have resulted in lower sales and increased operational complexities. Furthermore, despite a modest increase in cash and equivalents, the year-over-year decline in marketable securities by $58 million raises concerns about the company's financial stability and ability to effectively manage its resources in the face of these headwinds.